세계 성형외과용 기구 시장(2023년-2030년)

Overview

Plastic surgery is the structural and aesthetic restoration of body parts such as the face, arms, breasts, etc. Cosmetic plastic surgeries are increasingly performed on individuals due to advanced technological innovations, which improve the quality of procedures. Surgeons use plastic surgery instruments to perform plastic surgeries efficiently and safely.

Reconstructive surgery is done on abnormal structures of the body. The surgery helps correct developmental abnormalities, infection, trauma, etc. Cosmetic surgeries are accessible to everyone and are done to improve appearance. More than 94% of all procedures were seen in women, with 43% of college-aged patients acknowledging a readiness to undergo more surgeries.

Market Dynamics: Drivers & Restraints

Increasing number of plastic surgeries

Plastic surgeries are increasing worldwide because they can change personal appearance and replace physical defects. The number of aesthetic surgical procedures has increased in the past few years due to the easy accessibility to people in many dermatological clinics and specialty centers. According to the International Society of Aesthetic Plastic Surgery 2023 report, breast augmentation was the most common surgical procedure for women, with 2.2 million procedures and a significant increase of 29% compared to 2021.

Additionally, more than 85.7% of the total number of aesthetic procedures are performed in women, with procedures performed in men increasing by 18%. Liposuction was the most common surgical procedure in 2022 as in 2021, with more than 2.3 million procedures and a 21.1% increase.

According to the American Society for Aesthetic Plastic Surgery and the Brazilian Society of Plastic Surgery, 2023, liposuction is the most frequently performed cosmetic procedure globally, making up 19.9 percent of total aesthetic surgeries. Breast augmentation, at 18.9 percent of procedures, isn't far behind. Counting down the list, blepharoplasty came in at 11 percent, abdominoplasty at 8.7 percent, and rhinoplasty at 7.5 percent.

Complications after plastic surgery

Plastic surgery improves the appearance of the defective part of the body. However, iT comes with its risks and complications. The hazards after plastic surgery include infection at the site, fluid buildup, and edema. Blood clots and excessive bleeding are also seen. More adverse effects include pulmonary embolism and deep vein thrombosis, which leads to death. Nerve damage is observed, causing sensory or motor loss in the individual.

Segment Analysis

The global plastic surgery instruments are segmented based on product, application, end-user, and region.

The Handheld instruments segment accounted for approximately 48.3% of the market share

Hand-held instruments are expected to hold the largest market share. Hand-held devices are used chiefly while performing the surgeries. As the number of face, breast, and eyelid surgeries increases, hand-held instruments are preferred due to the precision they give to the surgeon while performing the surgery. Hence, there are growing launches of hand-held surgical devices in the market.

In May 2022, Tekno Surgical launched its Wexler Surgical range, specializing in titanium and stainless-steel surgical clamps, forceps, needle holders, scissors, retractors, diamond knives, dilators, speculums, cannulas, hooks, choppers, and spatulas, as well as single-use and instrument care products.

In September 2022 Medical Microinstruments launched its new super micro NanoWrist instruments, which access and suture small and delicate veins, for its Symani surgical robot.

Geographical Analysis

North America accounted for approximately 40.2% of the market share in 2022

North America is expected to hold the largest market share due to the annual number of plastic and cosmetic surgeries performed in us. For instance, according to the International Society of Aesthetic Plastic Surgery, 2022, the US conducted the most procedures worldwide with over 7.4 million procedures, 22% of the systems, followed by Brazil (8.9%) first in surgical procedures, and Japan (7.3%).

The US and Brazil are estimated to have the most plastic surgeons, followed by Asian countries, with Japan in third place, China in fourth, and South Korea in fifth.

According to North Raleigh Plastic Surgery, in 2023, with over 300,000 surgeries performed yearly, breast augmentation is the most popular cosmetic procedure in the United States, followed by Rhinoplasty and Blepharoplasty.

COVID-19 Impact Analysis:

COVID-19 moderately impacted the plastic surgery instruments market due to the implementation of lockdowns everywhere, which disrupted the supply chain. The hospitals prioritized individuals with COVID-19 due to its spread and risk factors. The shift in the focus towards vaccine development impacted the supply chain. The surgeries were postponed to later stages because of the rise in cases during the pandemic.

Competitive Landscape

The major global players in the plastic surgery instruments market include: DIMEDA Instrumente GmbH, Healermed Instruments, BlueMed Surgical, Gulmaher Surgico, Ambler Surgical, Henry Schein, Inc, KLS Martin Group, Hayden Medical Inc, TEKNO-MEDICAL Optik-Chirurgie GmbH, Surtex Instruments Limited among others.

Key Developments

• In December 2022, Integra LifeSciences Holding Corporation agreed to acquire Surgical Innovation Associates (SIA), a manufacturer of plastic surgery instruments. This agreement further strengthens Integra's plastic and reconstructive surgery portfolio

Why Purchase the Report?

• To visualize the global plastic surgery instruments market segmentation based on product, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of plastic surgery instruments market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global plastic surgery instruments market report would provide approximately 63 tables, 65 figures, and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product
• 3.2. Snippet by Application
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Driver
    • 4.1.1.1. Increasing number of plastic surgeries
    • 4.1.1.2.
  • 4.1.2. Restraints
    • 4.1.2.1. Complications after surgeries
    • 4.1.2.2.
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 7.1.2. Market Attractiveness Index, By Product
• 7.2. Handheld Instruments*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.2.1. Forceps
    • 7.2.2.2. Needle Holders
    • 7.2.2.3. Scissors
    • 7.2.2.4. Retractors
    • 7.2.2.5. Others
• 7.3. Electrosurgical Instruments
  • 7.3.1. Bipolar
  • 7.3.2. Monopolar
• 7.4. Others

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Reconstructive Surgery*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.2.1. Breast Reconstruction
    • 8.2.2.2. Congenital Deformity Correction
    • 8.2.2.3. Tumor Removal
    • 8.2.2.4. Others
• 8.3. Cosmetic Surgeries
  • 8.3.1.1. Face and Head Cosmetic Surgery
  • 8.3.1.2. Body & Extremities Cosmetic Procedures
  • 8.3.1.3. Breast Procedures
  • 8.3.1.4. Others
• 8.4. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Dermatology Clinics
• 9.4. Specialty Centers
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. DIMEDA Instrumente GmbH
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Healermed Instruments
• 12.3. BlueMed Surgical
• 12.4. Gulmaher Surgico
• 12.5. Ambler Surgical
• 12.6. Henry Schein, Inc
• 12.7. KLS Martin Group
• 12.8. Hayden Medical Inc
• 12.9. TEKNO-MEDICAL Optik-Chirurgie GmbH
• 12.10. Surtex Instruments Limited

LIST NOT EXHAUSTIVE.

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us